已核实 DOI 相关产品: 9

Preparation and Characterization of Novel Pharmaceutical Co-Crystals: Ticagrelor with Nicotinamide

Journal 2018 · IF 2.144 · 8(9): 336 · 发表于 2018 年 8 月 21 日
作者: Muhammad Inam,Jiajia Wu,Jie Shen,Chi Uyen Phan,Guping Tang,Xiurong Hu
阅读全文 在 PubMed 查看

摘要

Two new co-crystals, Ticagrelor with Nicotinamide, have been prepared with improved solubility. Because Ticalegor has a poor solubility and dissolution rate, a novel co-crystallization method with structurally homogenous crystalline material, an active pharmaceutical ingredient (API), and co-former indefinite stoichiometric amount has been made to improve Ticagrelor’s solubility. The co-crystal of Ticagrelor (TICA) with Nicotinamide (NCA) was prepared in ratio (1:1) and confirmed by FTIR, DSC, and XRD characterization. Furthermore, the single crystal structure of TICA-NCA hydrate was analyzed. The solubility of co-crystals was investigated in pH 2 acidic medium, which was a significant improvement as compared to the solubility of a free drug. The in vitro dissolution rate of co-crystal was larger than that of the commercial product.Keywords:co-crystal;ticagrelor;nicotinamide;solubility;dissolution

本研究中使用的阿拉丁产品

9 款产品在本文中被引用